Jefferies Initiates "Buy" On PROLOR Biotech
Long Ideas - Shares of PROLOR Biotech (NYSEAMEX:PBTH) are trading up this morning after Jefferies initiated a “Buy” rating with an $8 price target. The company develops a … Continue Reading
Read NowLong Ideas
New Intermezzo Patent And Orange Book Listing Are Major Positives For Transcept Pharma
Long Ideas - Transcept Pharmaceuticals (NASDAQ:TSPT) announced after the close yesterday that its newly issued patent (U.S. Patent No. 8,242,131, or the ‘131 patent) was posted in the … Continue Reading
Read NowPfizer: Tofacitinib Decision Delayed Until November
Long Ideas - Pfizer (NYSE:PFE) announced this morning that the FDA delayed a decision on its rheumatoid arthritis treatment Tofacitinib by at least three months. The agency was … Continue Reading
Read NowMedtronic Earnings Demonstrate Strengths, Negative St. Jude Article Could Energize The Stock
Long Ideas - Medtronic (NYSE:MDT) reported fiscal 1Q 2013 EPS of $0.85, in-line with expectations, with revenues also largely meeting forecasts ($4.01 billion vs. consensus estimate of $4.0 … Continue Reading
Read NowHyperion Gets Coverage From Two Analysts This Morning: $15 Target
Long Ideas - Hyperion Therapeutics (NASDAQ:HPTX) received two Buy ratings this morning after going public in late July. Both Cowen and Needham initiated coverage on HPTX, with Needham … Continue Reading
Read NowMedtronic Strength Could Continue Through Earnings Next Week
Long Ideas - Shares of Medtronic (NYSE:MDT) are expected to be strong today and through the company’s fiscal 1Q 2013 earnings report next week, with a big upgrade … Continue Reading
Read NowIdenix Suspension Makes Room for Gilead Sciences
Long Ideas - After yesterday’s news from Idenix Pharmaceuticals (NASDAQ:IDIX) and the ensuing 30% sell-off, Gilead Sciences (NASDAQ:GILD) saw a small decline in share price. Gilead’s lead Hepatitis … Continue Reading
Read Now